BDNF as a Mediator of Antidepressant Response: Recent Advances and Lifestyle Interactions
Open accessThe DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Abstract
Conventional antidepressants are widely employed in several psychiatric and neurologic disorders, yet the mechanisms underlying their delayed and partial therapeutic effects are only gradually being understood. This narrative review provides an up-to-date overview of the interplay between antidepressant treatment and Brain-Derived Neurotrophic Factor (BDNF) signaling. In addition, the impact of nutritional, environmental and physiological factors on BDNF and the antidepressant response is outlined. This review underlines the necessity to include information on lifestyle choices in testing and developing antidepressant treatments in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), have been shown to increase BDNF levels both in peripheral blood and in specific brain regions such as the hippocampus, which is critical for mood regulation and neurogenesis [3,41].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conventional antidepressants, particularly SSRIs and SNRIs, are known to increase BDNF levels over time, which correlates with their delayed therapeutic effect [3,41].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061 · cited 1×
“DNA methylation can directly silence genes through the formation of methylcytosine in CpG dinucleotide-rich regions known as CpG islands, which subsequently perturbs gene transcription near transcriptional start sites [58].”
BackgroundMalhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,566
Genetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431 · cited 1×
“Studies on gene-environment interactions may not only help to understand the pathophysiology of MDD but could also provide predictive factors for personalized antidepressant therapy [162,163].”
BackgroundA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 1×
“When direct BDNF infusions were administered in rodents, the inhibition of TrkB signaling prevented the antidepressant-like effects of BDNF [16,17].”
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 1×
“Environmental conditions, including stressful or traumatic events are known risk factors to depression [170].”
BackgroundThe Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181 · cited 1×
“Cortisol is increased in patients suffering from MDD [172] and is thought to impair serotonin transmission [173].”
BackgroundA molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · cited 1×
“Instead, starting from the work of Duman and collaborators [4], novel molecular and cellular mechanisms were identified, highlighting the role of second messenger systems, which are involved in gene expression regulation [5].”
Background
Cited by
From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine
Toader, C., Șerban, M., Munteanu, O., Covache-Busuioc, R.-A., Enyedi, M., Ciurea, A. V., & Tătaru, C. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094271 · Cited by 185
Cavaleri, D., Moretti, F., Bartoccetti, A., Mauro, S., Crocamo, C., Carrà, G., & Bartoli, F. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105159 · Cited by 146
Treatment-resistant depression: molecular mechanisms and management
Kajumba, M. M., Kakooza‐Mwesige, A., Nakasujja, N., Attix, D. K., & Canli, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00205-y · Cited by 106
“…an increase in BDNF-TrkB signaling is required in antidepressant treatment response, and the BDNF-related adaptations following prolonged use of antide-pressants are consistent with the duration of weeks or months required for the conventional antidepressants to induce therapeutic effects [180].”
BackgroundȘerban, M., Toader, C., & Covache-Busuioc, R.-A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157498 · Cited by 74
Lei, M., Liu, Q., Nie, J., Huang, R., Mei, Y., Pan, D., Chen, Y., & Liu, W. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70138 · Cited by 71
“Further, BDNF plays a crucial role in most antidepressant treatments and is further associated with neurodegenerative diseases and neurological disorders such as schizophrenia [81].”
Pardossi, S., Fagiolini, A., & Cuomo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313098 · Cited by 51
“Conventional antidepressants, particularly SSRIs and SNRIs, are known to increase BDNF levels over time, which correlates with their delayed therapeutic effect [3,41].”
InfluentialGut-brain axis: altered microbiome and depression – review
Mohan, A., Godugu, S., Joshi, S., Shah, K. B., Vanka, S. C., Shakil, H., Dhanush, P., Veliginti, S., Sure, P. S., & Goranti, J. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000573 · Cited by 31
“In rodents with a learned helplessness model of depression, BDNF infusion lowers escape latencies and failure rates([23]).”
BackgroundPerković, M. N., Gredičak, M., Šagud, M., Erjavec, G. N., Uzun, S., & Pivac, N. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2200937 · Cited by 28
“The neurotrophic hypothesis of depression is also supported by the ability of antidepressant treatment to restore neuronal atrophy and cell loss through neurotrophic actions [6,7].”
BackgroundResultInfluentialHan, M., Zeng, D., Tan, W., Chen, X.-X., Bai, S.-Y., Wu, Q., Chen, Y., Wei, Z., Mei, Y., & Zeng, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01419 · Cited by 23
“However, the BDNF signaling pathway is also important in the mechanism underlying the effectiveness of antidepressants (Rosenhauer et al., 2019; Castren and Monteggia, 2021; Cubillos et al., 2022; Cavaleri et al., 2023).”
BackgroundPiriyaprasath, K., Kakihara, Y., Kurahashi, A., Taiyoji, M., Kodaira, K., Aihara, K., Hasegawa, M., Yamamura, K., & Okamoto, K. (2023) · Nutrients · doi:10.3390/nu15183989 · Cited by 17
“Because changes in BDNF signaling can cause psychological illness and chronic pain [35], measurements of the level of BDNF in SH-SY5Y cells supported the idea that Rice-koji and EGT exert modulatory effects on neural functions at the cellular level.”
BackgroundChen, N., Zhao, M., Guo, Y., Wu, N., Cao, B., Zhan, B., Zhou, T., Li, Y., Zhu, F., Chen, W., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02636-7 · Cited by 16
“Nonetheless, there is no doubt that rapid elevation of BDNF is a crucial contributor to fast-acting and long-term antidepressant responses [22].”
Ning, B., Ge, T., Wu, Y., Wang, Y., & Zhao, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03758-1 · Cited by 13
“In addition, improving lifestyle and maintaining mental health can also increase BDNF levels [152].”
Walaszek, M., Kachlik, Z., & Cubała, W. J. (2024) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2303218 · Cited by 16
“BDNF and its receptor – neurotrophic receptor tyrosine kinase 2 (TrkB) play an important role in depression pathophysiology in a scope of neuroplasticity thus this neurotrophic factor may be called ‘ brain fertilizer ’ [55,61,62].”
Castro, S. C. C., Bicca, C., Bicca, B., Araujo, S., & Viola, T. W. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1143332 · Cited by 13
“Particularly, enhancement of the BDNF signaling through epigenetic regulation and increased gene expression has been suggested to be a molecular mechanism of action of conventional antidepressants (Cubillos et al., 2022).”
BackgroundLv, H., Gao, Z., Wang, Y., Chen, S., Liu, P., Xie, Y., Guan, M., Cong, J., & Xu, Y. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04012-9 · Cited by 10
“Furthermore, BDNF signaling exerts a key role in the pathogenesis and treatment of depression [47].”
BackgroundPaolini, M., Fortaner-Uyà, L., Lorenzi, C., Spadini, S., Maccario, M., Zanardi, R., Colombo, C., Poletti, S., & Benedetti, F. (2023) · Genes · doi:10.3390/genes14112037 · Cited by 13
“BDNF in turn enhances neural plasticity in depressed brains, a process thought to be crucial in ameliorating depressive symptomatology [97]; precisely for this reason, it is considered to be a crucial mediator of antidepressant effects [98,99].”
BackgroundSmit, A. J. T., Wu, G. W. Y., Rampersaud, R., Reus, V. I., Wolkowitz, O. M., & Mellon, S. H. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107045 · Cited by 9
“…sampling (Matrisciano et al., 2009; Zhou et al., 2017; Arosio et al., 2021), demographic features such as sex, age and physical activity levels (Cubillos, Engmann and Brancato, 2022; Kramer et al., 2023), platelet number and reactivity (Naegelin et al., 2018; Kallies et al., 2019; Kronenberg…”
BackgroundThe Exciting Frontier of Neuroplasticity: Innovations in Brain Health and Recovery
Saha, R. (2025) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2025.153003 · Cited by 10
Tekmeh, H. H., Kural, B. V., Kör, S., Malkoç, M. A., Yuluğ, E., Kutlu, A., Abidin, İ., & Örem, A. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.039 · Cited by 10
Imiuwa, M. E., Baynes, A., & Routledge, E. J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287582 · Cited by 12
Matsuzaka, Y., & Yashiro, R. (2025) · Biologics · doi:10.3390/biologics5010007 · Cited by 11
“Therefore, the pathway of repairing neural networks by improving synaptic plasticity through activation of the BDNF-TrkB system is an important mechanism of action for antidepressants, in addition to their effects on monoaminergic systems [121,130].”
InfluentialDysregulation of FGFR1 signaling in the hippocampus facilitates depressive disorder
Shin, J., Oh, H., Park, J. H., Bae, H., Yang, C.-M., Lee, M., Kim, S., & Heo, W. D. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01519-9 · Cited by 9
Are BDNF and Stress Levels Related to Antidepressant Response?
Flores‐Ramos, M., Vega-Rosas, A., Palomera-Garfias, N., Saracco-Álvarez, R. A., & Ramírez-Rodríguez, G. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910373 · Cited by 7
“It is well established that there is an interplay between BDNF and depressive disorder [26], especially as a good classifier of MDD diagnosis.”
BackgroundOlivier, N., Harvey, B. H., Gobec, S., Shahid, M., Košak, U., Žakelj, S., & Brink, C. B. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118093 · Cited by 7
Perlikowska, R., Długosz-Pokorska, A., Domowicz, M., Grabowicz, S., Stasiołek, M., & Zakłos‐Szyda, M. (2025) · Biomedicines · doi:10.3390/biomedicines13071774 · Cited by 8
“Patients who respond well to treatment often show significant increases in BDNF, suggesting its potential as a biomarker for treatment efficacy [37].”
Tiongco, R. E., Arbas, R., Caguiat, A., Castro, E. J., Cruz, K. C. D., Dominguez, M. J., Guintu, M. A. A. D., Mercado, J. A., & Vallo, J. (2025) · Personalized Medicine · doi:10.1080/17410541.2025.2544352 · Cited by 10
Chen, L., Wang, X., Jia, X., Bade, R., Liu, X., Jiang, S., Xie, Y., Xie, W., Gao, M., & Shao, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-00355-1 · Cited by 6
Inozemtseva, L. S., Yatsenko, K. A., Glazova, N. Y., Kamensky, A. A., Myasoedov, N. F., Levitskaya, N. G., Grivennikov, I. A., & Dolotov, O. V. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177068 · Cited by 5
Npbwr1 signaling mediates fast antidepressant action
Stein, G., Aly, J. S., Lange, L. D., Manzolillo, A., Riege, K., Brancato, A., Huebner, A. K., Turecki, G., Hoffmann, S., & Engmann, O. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02790-4 · Cited by 7
“RNA-sequencing after viral overexpression of Npbwr1 provides a link to Bdnf , a key gene in the antidepressant response [15].”
Self-citationTao, S., Yu, L., Li, J., Wu, J., Yang, D., Huang, X., & Xue, T. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1495467 · Cited by 6
“Antidepressants, pharmacotherapy, lifestyle modi fi cations, psychotherapy, electroconvulsive therapy, and vagal nervous stimulation are all options for treating depression (3 – 6).”
Neurotrophic Factors as Markers of Stroke Recovery: a Review
Kostenko, E. V., Петрова, Л. В., Egorov, P. D., Pogonchenkova, I. V., & Сергеевич, Ф. М. (2025) · Bulletin of Rehabilitation Medicine · doi:10.38025/2078-1962-2025-24-3-123-139 · Cited by 3
Effects of heat environments on depressive disorders: Neurogenesis-mediated mechanisms
Kong, M.-H., Li, Q., & Chen, X. (2025) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2025.104304 · Cited by 3
Stress und Depression – eine neurobiologische Perspektive
Hinkelmann, K., & Rose, M. (2024) · HNO · doi:10.1007/s00106-024-01500-4 · Cited by 4
Piriyaprasath, K., Hasegawa, M., Kakihara, Y., Iwamoto, Y., Kamimura, R., Saito, I., Fujii, N., Yamamura, K., & Okamoto, K. (2023) · European Journal Of Oral Sciences · doi:10.1111/eos.12942 · Cited by 5
Johnson, D., Ramachandram, D. S., Doorly, J., Clarke, G. A., Chan, K., Thurairajasingam, S., Lee, L.-H., & Letchumanan, V. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251397332 · Cited by 3
“These findings are consistent with broader evidence implicating BDNF and hippocampal plasticity in antidepressant response, but direct causal links remain to be demonstrated (Cubillos et al., 2022; Li et al., 2025; Rosas-Sánchez et al., 2024).”
Neurochemical biomarkers in major depressive disorder
Khatami, S. H., Chamardani, T. M., Motamedzadeh, A., Nateghi, M., & Dadgostar, E. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120936 · Cited by 2
Kachlik, Z., Walaszek, M., & Cubała, W. J. (2024) · Medical Hypotheses · doi:10.1016/j.mehy.2024.111356 · Cited by 1
The role of neurotrophic factors during rehabilitation therapy in patients with cerebral palsy
Korsunskaya, L. L., Агеева, Е. С., & Ларина, Н. В. (2025) · Russian neurological Journal · doi:10.30629/2658-7947-2024-29-5-23-30 · Cited by 1
Singh, K., Blostein, F., Wells, Q. S., Hodges, E. C., Cox, N. J., & Davis, L. K. (2025) · medRxiv · doi:10.1101/2025.10.13.25337946
Antioxidants as immunomodulators for Tau and Amyloid-β in Alzheimer’s disease
Chinnathambi, S., Rangappa, N., & Chandrashekar, M. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.007
Diabetes-Induced depression: A molecular perspective
Hedayati‐Moghadam, M., Razazpour, F., Mirzaee, F., Hakemi, Z., Dalfardi, M., & Baghcheghi, Y. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01806-2 · Cited by 1
Okey, S. M., & Jimoh, A. (2026) · African Research Reports · doi:10.65221/0229
Massetti, S., Smith-Apeldoorn, S. Y., Veraart, J. K. E., Kamphuis, J., Muller, K. A., Tzavara, E. T., Meerlo, P., Schoevers, R. A., & van Dalfsen, J. H. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122265
Anxiolytic and antidepressant potential of psychobiotics
Sergeev, Y. A., Beyer, E., & Bazikov, I. A. (2026) · Kazan medical journal · doi:10.17816/kmj699666
“В част ности, кратное снижение этого показателя свидетельству ет о прогрессирующем депрессивном расстройстве [46].”
Batur, L. K., Pektas, A., Aslan, B., Akçalı, N., Mustafa, Z., Uğurlu, A., Hacıosmanoğlu, E., & Üstünova, S. (2026) · Biomedicines · doi:10.3390/biomedicines14081749
“In particular, NTRK2 is noteworthy because it forms a functional bridge between monoaminergic mechanisms and neurotrophic/synaptic plasticity responses [11,12,17].”
Ni, J., Qiao, M.-X., Lin, Y.-G., Yu, H., & Li, T. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.08.001
Deng, J., Shao, Y., Jiang, L., Wu, B., Roberts, N., Wang, Q., & Jia, Z. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03930-8
Metadata
- Authors
- Cubillos, S., Engmann, O., & Brancato, A.
- Affiliations
- Friedrich Schiller University Jena (DE)
- University of Palermo (IT)
- Corresponding author
- Engmann, Olivia
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-11-21
- Volume
- 23
- Issue
- 22
- Pages
- 14445
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9698349
- OpenAlex
- W4309787614
- Cited by
- 47
- References
- 214
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 13 · 2023: 12
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS UniPA (University of Palermo) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Common Library Network (Der Gemeinsame Bibliotheksverbund) (submittedVersion, cc-by)
- Funders
- Carl-Zeiss-Foundation (#P2019-01-0006, 737/2021, FFR 2019/2022)
- European Union—NextGenerationEU (#P2019-01-0006, 737/2021, FFR 2019/2022)
- University of Palermo (#P2019-01-0006, 737/2021, FFR 2019/2022)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- brain-derived neurotrophic factor, antidepressant response, antidepressant mechanism, BDNF signaling, lifestyle factors, nutrition, environmental factors, physiological factors, antidepressant drug development
- MeSH terms
- Antidepressive Agents, Signal Transduction, Brain-Derived Neurotrophic Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.